About CURRENT Med Diag & Treatment
"Try before you buy" - Download the FREE App, which includes sample content. An in-App purchase is required to unlock all content. The #1 annual guide in adult internal medicine. Each year CURRENT Medical Diagnosis and...
"Try before you buy" - Download the FREE App, which includes sample content. An in-App purchase is required to unlock all content. The #1 annual guide in adult internal medicine. Each year CURRENT Medical Diagnosis and Treatment (CMDT) undergoes extensive revision to deliver new clinical developments in every field of adult internal medicine-making it the most popular annual textbook of its kind. For more than six decades, CMDT has been disseminating authoritative information that students, residents, and clinicians need to build their medical knowledge, expertise, and confidence. Written by top experts in their fields, chapters are formatted so you can find the most relevant diagnostic tools for day-to-day practice. CURRENT Medical Diagnosis & Treatment 2025 provides: - Emphasis on the practical aspects of clinical diagnosis and disease management - Coverage of more than 1,000 diseases and disorders - Hundreds of quick-access drug treatment tables with indexed trade names - Essentials of Diagnosis provides snapshot of common diseases/disorders - Diagnostic and treatment algorithms and tables present critical information at a glance - Carefully curated references provide peer-reviewed, evidence-based information and PMID numbers for quick online access - Hundreds of full-color photographs and illustrations CMDT 2025 updates include: “Year in Review” table highlights nearly 100 recent advances - impacting clinical practice - New chapter on Substance Use Disorders - New photos reflecting clinical conditions in a variety of skin tones - Key updates to Viral & Rickettsial Infections chapter including concise directives on COVID-19 and measles - Expanded coverage of major GI Disorders such as Crohn disease and ulcerative colitis No internet connection is required to access the content after the initial download. Find information quickly using powerful SmartSearch technology. Search part of term for those hard to spell medical terms. Content licensed from printed ISBN 10: 1266266232 Content licensed from printed ISBN 13: 9781266266232 SUBSCRIPTION : Please choose an auto renewable subscription plan to receive content access & continuous updates. Your subscription automatically renews as per your plan, so you always have the latest content. Yearly auto-renewing payments-$64.99 Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user & auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000 Privacy Policy-https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions-https://www.skyscape.com/terms-of-service/licenseagreement.aspx Editor(s): Maxine A. Papadakis, Michael W. Rabow, Kenneth R. McQuaid, Monica Gandhi Publisher: The McGraw-Hill Companies, Inc.
Version History * Improved app stability and resolved crash issues for a smoother experience. * Added a Force Update feature to ensure you have access to the latest app version and improvements. * Enhanced app performance and reliability. * General bug fixes and improvements. 5.10.0 Aug 26 - Minor Bug Fixes 5.8.5 11/13/2025 - Minor Bug Fixes 5.7.8 06/05/2025 - Minor Bug Fixes - UI-UX enhancements 5.7.4 05/29/2025 Get the best experience of connecting with communities, engaging with them with recent news, alerts, your favorite topics. Preview quick videos and watch them right on your devices. And in this release, we have also fixed bugs and made performance improvements. Just for you. 5.7.1 02/26/2025 - 2025 Update with evidence-based coverage of more than 1,000 diseases and disorders - Minor Bug Fixes - UI-UX enhancements 5.5.5 12/18/2024 - Latest USPSFT recommendations for cardiovascular risk prevention - Significant new opioid prescribing guidelines from the CDC - Clarification on the distinction between uncontrolled hypertensive and hypertension emergency - Latest classification of lymphomas released by the WHO - Recommendations for the initiation and titration of treatment for chronic hypertension in pregnancy - Current treatment guidelines and medications for H pylori infection - Classification of the role, dosing, and potential risks of JAK inhibitors and anti-23 antibody (Risankizumab) in the treatment of IBD - Updates that underscore the growing utility of combination treatments for high LDL levels, especially among high and very high-risk patients - The WHO revision of the pathological classification of renal cell carcinoma to assist with prognosis prediction and treatment decisions 5.2.1 04/12/2024 Experience the full power of having CURRENT Medical Diagnosis and Treatment in a mobile app, check out these feature releases: - Single-source reference for practitioners of adult medicine in both hospital and ambulatory settings - Medical advances up to time of annual publication - Detailed presentation of internal medicine disciplines, plus primary care topics in gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, women's health, sexual and gender minority health, preventive medicine, and palliative care - Concise format, facilitating efficient use in any practice setting - More than 1000 diseases and disorders - Specific disease prevention information - Easy access to medication dosages, with trade names indexed and current costs updated in each annual edition - Audio notes: to quickly record notes on the go - Text notes: to record notes if you prefer - Zoom in or out on images with pinch action - Robust Indices for quick navigation like Image index & Table Index - Smart search: search content for a term or topic to find information quickly - History tracks your searches so you can revisit the topic when charting or care planning - Bookmark topics that you frequently access 5.1.2 01/30/2024 Experience the full power of having CURRENT Medical Diagnosis and Treatment in a mobile app, check out these feature releases: - Single-source reference for practitioners of adult medicine in both hospital and ambulatory settings - Medical advances up to time of annual publication - Detailed presentation of internal medicine disciplines, plus primary care topics in gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, women's health, sexual and gender minority health, preventive medicine, and palliative care - Concise format, facilitating efficient use in any practice setting - More than 1000 diseases and disorders - Specific disease prevention information - Easy access to medication dosages, with trade names indexed and current costs updated in each annual edition - Audio notes: to quickly record notes on the go - Text notes: to record notes if you prefer - Zoom in or out on images with pinch action - Robust Indices for quick navigation like Image index & Table Index - Smart search: search content for a term or topic to find information quickly - History tracks your searches so you can revisit the topic when charting or care planning - Bookmark topics that you frequently access 5.1.1 09/21/2023 NEW TO THIS EDITION - Ongoing concerted effort to address and remove unconscious bias - List of Common Abbreviations used in CMDT - New section on opioids for pain management - Overhauled organization of Dermatology topics to better reflect categorization of conditions and lesions - Expanded section of interventional therapies to manage chronic pain - Updated USPSTF lung cancer screening recommendations using low-dose CT - New prognostic systems for primary myelofibrosis: GIPSS and MIPSSv2 - Discussion of the use of DOACs in patients with morbid obesity who require antithrombotic therapy - Updated section on osmotic laxatives to treat chronic constipation - Ozanimod approved for the treatment of moderate to severe ulcerative colitis - Landmark change in staging female breast carcinoma modifying anatomic stage and adding prognostic stage - New medications for treating metastatic breast cancer (olaparib, talazoparib, palbociclib, ribociclib, and abemaciclib) - New recommendations on treating cholestasis of pregnancy - Updated criteria for diagnosing systemic lupus erythematosus to include antinuclear antibody measurement - New medications for active lupus nephritis, including voclosporin used with mycophenolate mofetil as well as belimumab - Anifrolumab is approved for nonrenal lupus when standard therapies fail - New guidelines for diagnosing polyarteritis nodosa - New American College of Rheumatology/Vasculitis Foundation recommendations for the treatment of granulomatosis with polyangiitis - A newly described genetic syndrome, VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) in the differential diagnosis of relapsing polychondritis - Discussion of the role of left atrial appendage closure in preventing stroke and systemic embolization - Aducanumab (anti-amyloid therapy) is approved by the US FDA for the treatment of Alzheimer disease - Extensive revision of the Thyroiditis section in Endocrine Disorders topic - Substantial revision of the Nutritional Support section in the Nutritional Disorders & Obesity topic - Substantial revision in the HIV Infection & AIDS chapter, including updates in the available therapeutic regimens - Rewritten SARS-CoV-2 section and inclusion of SARS-CoV-2 information relevant to specific chapters throughout the textbook - Extensive revision of Sexual & Gender Minority Health chapter, including sections on family planning and health care for transgender and gender diverse persons 5.0.10 03/28/2023 - Minor bug fixes. 5.0.6 02/24/2022 NEW Lower Price Purchase Options 5.0.3 05/27/2021 - Split Screen view for Mac and iPad - Dark Mode 5.0.1 04/09/2021 Fixes related to connecting to iTunes for in-app purchases in iOS version 13.4 and above 4.3.2 06/04/2020 Critical Medical Content Update, Bug fixes and New UI/UX 4.0 07/11/2019 - UI/UX enhancements - Minor bug fixes 3.1.3 02/14/2018 2.1.0 12/29/2017
Previous Versions
Here you can find the changelog of CURRENT Med Diag & Treatment since it was posted on our website on 2023-09-06 18:54:19.
The latest version is 5.10.0 and it was updated on 2026-10-14 18:11:23. See below the changes in each version.
CURRENT Med Diag & Treatment version 5.10.0
Updated At: 2026-10-14
Changes: Version History * Improved app stability and resolved crash issues for a smoother experience.
* Added a Force Update feature to ensure you have access to the latest app version and improvements.
* Enhanced app performance and reliability.
* General bug fixes and improvements. 5.10.0 Aug 26 - Minor Bug Fixes 5.8.5 11/13/2025 - Minor Bug Fixes 5.7.8 06/05/2025 - Minor Bug Fixes
- UI-UX enhancements 5.7.4 05/29/2025 Get the best experience of connecting with communities, engaging with them with recent news, alerts, your favorite topics.
Preview quick videos and watch them right on your devices.
And in this release, we have also fixed bugs and made performance improvements. Just for you. 5.7.1 02/26/2025 - 2025 Update with evidence-based coverage of more than 1,000 diseases and disorders
- Minor Bug Fixes
- UI-UX enhancements 5.5.5 12/18/2024 - Latest USPSFT recommendations for cardiovascular risk prevention
- Significant new opioid prescribing guidelines from the CDC
- Clarification on the distinction between uncontrolled hypertensive and hypertension emergency
- Latest classification of lymphomas released by the WHO
- Recommendations for the initiation and titration of treatment for chronic hypertension in pregnancy
- Current treatment guidelines and medications for H pylori infection
- Classification of the role, dosing, and potential risks of JAK inhibitors and anti-23 antibody (Risankizumab) in the treatment of IBD
- Updates that underscore the growing utility of combination treatments for high LDL levels, especially among high and very high-risk patients
- The WHO revision of the pathological classification of renal cell carcinoma to assist with prognosis prediction and treatment decisions 5.2.1 04/12/2024 Experience the full power of having CURRENT Medical Diagnosis and Treatment in a mobile app, check out these feature releases:
- Single-source reference for practitioners of adult medicine in both hospital and ambulatory settings
- Medical advances up to time of annual publication
- Detailed presentation of internal medicine disciplines, plus primary care topics in gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, women's health, sexual and gender minority health, preventive medicine, and palliative care
- Concise format, facilitating efficient use in any practice setting
- More than 1000 diseases and disorders
- Specific disease prevention information
- Easy access to medication dosages, with trade names indexed and current costs updated in each annual edition
- Audio notes: to quickly record notes on the go
- Text notes: to record notes if you prefer
- Zoom in or out on images with pinch action
- Robust Indices for quick navigation like Image index & Table Index
- Smart search: search content for a term or topic to find information quickly
- History tracks your searches so you can revisit the topic when charting or care planning
- Bookmark topics that you frequently access 5.1.2 01/30/2024 Experience the full power of having CURRENT Medical Diagnosis and Treatment in a mobile app, check out these feature releases:
- Single-source reference for practitioners of adult medicine in both hospital and ambulatory settings
- Medical advances up to time of annual publication
- Detailed presentation of internal medicine disciplines, plus primary care topics in gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, women's health, sexual and gender minority health, preventive medicine, and palliative care
- Concise format, facilitating efficient use in any practice setting
- More than 1000 diseases and disorders
- Specific disease prevention information
- Easy access to medication dosages, with trade names indexed and current costs updated in each annual edition
- Audio notes: to quickly record notes on the go
- Text notes: to record notes if you prefer
- Zoom in or out on images with pinch action
- Robust Indices for quick navigation like Image index & Table Index
- Smart search: search content for a term or topic to find information quickly
- History tracks your searches so you can revisit the topic when charting or care planning
- Bookmark topics that you frequently access 5.1.1 09/21/2023 NEW TO THIS EDITION
- Ongoing concerted effort to address and remove unconscious bias
- List of Common Abbreviations used in CMDT
- New section on opioids for pain management
- Overhauled organization of Dermatology topics to better reflect categorization of conditions and lesions
- Expanded section of interventional therapies to manage chronic pain
- Updated USPSTF lung cancer screening recommendations using low-dose CT
- New prognostic systems for primary myelofibrosis: GIPSS and MIPSSv2
- Discussion of the use of DOACs in patients with morbid obesity who require antithrombotic therapy
- Updated section on osmotic laxatives to treat chronic constipation
- Ozanimod approved for the treatment of moderate to severe ulcerative colitis
- Landmark change in staging female breast carcinoma modifying anatomic stage and adding prognostic stage
- New medications for treating metastatic breast cancer (olaparib, talazoparib, palbociclib, ribociclib, and abemaciclib)
- New recommendations on treating cholestasis of pregnancy
- Updated criteria for diagnosing systemic lupus erythematosus to include antinuclear antibody measurement
- New medications for active lupus nephritis, including voclosporin used with mycophenolate mofetil as well as belimumab
- Anifrolumab is approved for nonrenal lupus when standard therapies fail
- New guidelines for diagnosing polyarteritis nodosa
- New American College of Rheumatology/Vasculitis Foundation recommendations for the treatment of granulomatosis with polyangiitis
- A newly described genetic syndrome, VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) in the differential diagnosis of relapsing polychondritis
- Discussion of the role of left atrial appendage closure in preventing stroke and systemic embolization
- Aducanumab (anti-amyloid therapy) is approved by the US FDA for the treatment of Alzheimer disease
- Extensive revision of the Thyroiditis section in Endocrine Disorders topic
- Substantial revision of the Nutritional Support section in the Nutritional Disorders & Obesity topic
- Substantial revision in the HIV Infection & AIDS chapter, including updates in the available therapeutic regimens
- Rewritten SARS-CoV-2 section and inclusion of SARS-CoV-2 information relevant to specific chapters throughout the textbook
- Extensive revision of Sexual & Gender Minority Health chapter, including sections on family planning and health care for transgender and gender diverse persons 5.0.10 03/28/2023 - Minor bug fixes. 5.0.6 02/24/2022 NEW Lower Price Purchase Options 5.0.3 05/27/2021 - Split Screen view for Mac and iPad
- Dark Mode 5.0.1 04/09/2021 Fixes related to connecting to iTunes for in-app purchases in iOS version 13.4 and above 4.3.2 06/04/2020 Critical Medical Content Update, Bug fixes and New UI/UX 4.0 07/11/2019 - UI/UX enhancements
- Minor bug fixes 3.1.3 02/14/2018 2.1.0 12/29/2017
CURRENT Med Diag & Treatment version 5.8.5
Updated At: 2026-08-13
Changes: Version History - Minor Bug Fixes 5.8.5 11/13/2025 - Minor Bug Fixes 5.7.8 06/05/2025 - Minor Bug Fixes
- UI-UX enhancements 5.7.4 05/29/2025 Get the best experience of connecting with communities, engaging with them with recent news, alerts, your favorite topics.
Preview quick videos and watch them right on your devices.
And in this release, we have also fixed bugs and made performance improvements. Just for you. 5.7.1 02/26/2025 - 2025 Update with evidence-based coverage of more than 1,000 diseases and disorders
- Minor Bug Fixes
- UI-UX enhancements 5.5.5 12/18/2024 - Latest USPSFT recommendations for cardiovascular risk prevention
- Significant new opioid prescribing guidelines from the CDC
- Clarification on the distinction between uncontrolled hypertensive and hypertension emergency
- Latest classification of lymphomas released by the WHO
- Recommendations for the initiation and titration of treatment for chronic hypertension in pregnancy
- Current treatment guidelines and medications for H pylori infection
- Classification of the role, dosing, and potential risks of JAK inhibitors and anti-23 antibody (Risankizumab) in the treatment of IBD
- Updates that underscore the growing utility of combination treatments for high LDL levels, especially among high and very high-risk patients
- The WHO revision of the pathological classification of renal cell carcinoma to assist with prognosis prediction and treatment decisions 5.2.1 04/12/2024 Experience the full power of having CURRENT Medical Diagnosis and Treatment in a mobile app, check out these feature releases:
- Single-source reference for practitioners of adult medicine in both hospital and ambulatory settings
- Medical advances up to time of annual publication
- Detailed presentation of internal medicine disciplines, plus primary care topics in gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, women's health, sexual and gender minority health, preventive medicine, and palliative care
- Concise format, facilitating efficient use in any practice setting
- More than 1000 diseases and disorders
- Specific disease prevention information
- Easy access to medication dosages, with trade names indexed and current costs updated in each annual edition
- Audio notes: to quickly record notes on the go
- Text notes: to record notes if you prefer
- Zoom in or out on images with pinch action
- Robust Indices for quick navigation like Image index & Table Index
- Smart search: search content for a term or topic to find information quickly
- History tracks your searches so you can revisit the topic when charting or care planning
- Bookmark topics that you frequently access 5.1.2 01/30/2024 Experience the full power of having CURRENT Medical Diagnosis and Treatment in a mobile app, check out these feature releases:
- Single-source reference for practitioners of adult medicine in both hospital and ambulatory settings
- Medical advances up to time of annual publication
- Detailed presentation of internal medicine disciplines, plus primary care topics in gynecology, obstetrics, dermatology, ophthalmology, otolaryngology, psychiatry, neurology, toxicology, urology, geriatrics, orthopedics, women's health, sexual and gender minority health, preventive medicine, and palliative care
- Concise format, facilitating efficient use in any practice setting
- More than 1000 diseases and disorders
- Specific disease prevention information
- Easy access to medication dosages, with trade names indexed and current costs updated in each annual edition
- Audio notes: to quickly record notes on the go
- Text notes: to record notes if you prefer
- Zoom in or out on images with pinch action
- Robust Indices for quick navigation like Image index & Table Index
- Smart search: search content for a term or topic to find information quickly
- History tracks your searches so you can revisit the topic when charting or care planning
- Bookmark topics that you frequently access 5.1.1 09/21/2023 NEW TO THIS EDITION
- Ongoing concerted effort to address and remove unconscious bias
- List of Common Abbreviations used in CMDT
- New section on opioids for pain management
- Overhauled organization of Dermatology topics to better reflect categorization of conditions and lesions
- Expanded section of interventional therapies to manage chronic pain
- Updated USPSTF lung cancer screening recommendations using low-dose CT
- New prognostic systems for primary myelofibrosis: GIPSS and MIPSSv2
- Discussion of the use of DOACs in patients with morbid obesity who require antithrombotic therapy
- Updated section on osmotic laxatives to treat chronic constipation
- Ozanimod approved for the treatment of moderate to severe ulcerative colitis
- Landmark change in staging female breast carcinoma modifying anatomic stage and adding prognostic stage
- New medications for treating metastatic breast cancer (olaparib, talazoparib, palbociclib, ribociclib, and abemaciclib)
- New recommendations on treating cholestasis of pregnancy
- Updated criteria for diagnosing systemic lupus erythematosus to include antinuclear antibody measurement
- New medications for active lupus nephritis, including voclosporin used with mycophenolate mofetil as well as belimumab
- Anifrolumab is approved for nonrenal lupus when standard therapies fail
- New guidelines for diagnosing polyarteritis nodosa
- New American College of Rheumatology/Vasculitis Foundation recommendations for the treatment of granulomatosis with polyangiitis
- A newly described genetic syndrome, VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) in the differential diagnosis of relapsing polychondritis
- Discussion of the role of left atrial appendage closure in preventing stroke and systemic embolization
- Aducanumab (anti-amyloid therapy) is approved by the US FDA for the treatment of Alzheimer disease
- Extensive revision of the Thyroiditis section in Endocrine Disorders topic
- Substantial revision of the Nutritional Support section in the Nutritional Disorders & Obesity topic
- Substantial revision in the HIV Infection & AIDS chapter, including updates in the available therapeutic regimens
- Rewritten SARS-CoV-2 section and inclusion of SARS-CoV-2 information relevant to specific chapters throughout the textbook
- Extensive revision of Sexual & Gender Minority Health chapter, including sections on family planning and health care for transgender and gender diverse persons 5.0.10 03/28/2023 - Minor bug fixes. 5.0.6 02/24/2022 NEW Lower Price Purchase Options 5.0.3 05/27/2021 - Split Screen view for Mac and iPad
- Dark Mode 5.0.1 04/09/2021 Fixes related to connecting to iTunes for in-app purchases in iOS version 13.4 and above 4.3.2 06/04/2020 Critical Medical Content Update, Bug fixes and New UI/UX 4.0 07/11/2019 - UI/UX enhancements
- Minor bug fixes 3.1.3 02/14/2018 2.1.0 12/29/2017
CURRENT Med Diag & Treatment version 5.8.5
Updated At: 2025-11-13
Changes: - Minor Bug Fixes
CURRENT Med Diag & Treatment version 5.0.10
Updated At: 2023-03-30
Changes: Mar 30, 2023
Version 5.0.10
NEW TO THIS EDITION
- Ongoing concerted effort to address and remove unconscious bias
- List of Common Abbreviations used in CMDT
- New section on opioids for pain management
- Overhauled organization of Dermatology topics to better reflect categorization of conditions and lesions
- Expanded section of interventional therapies to manage chronic pain
- Updated USPSTF lung cancer screening recommendations using low-dose CT
- New prognostic systems for primary myelofibrosis: GIPSS and MIPSSv2
- Discussion of the use of DOACs in patients with morbid obesity who require antithrombotic therapy
- Updated section on osmotic laxatives to treat chronic constipation
- Ozanimod approved for the treatment of moderate to severe ulcerative colitis
- Landmark change in staging female breast carcinoma modifying anatomic stage and adding prognostic stage
- New medications for treating metastatic breast cancer (olaparib, talazoparib, palbociclib, ribociclib, and abemaciclib)
- New recommendations on treating cholestasis of pregnancy
- Updated criteria for diagnosing systemic lupus erythematosus to include antinuclear antibody measurement
- New medications for active lupus nephritis, including voclosporin used with mycophenolate mofetil as well as belimumab
- Anifrolumab is approved for nonrenal lupus when standard therapies fail
- New guidelines for diagnosing polyarteritis nodosa
- New American College of Rheumatology/Vasculitis Foundation recommendations for the treatment of granulomatosis with polyangiitis
- A newly described genetic syndrome, VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) in the differential diagnosis of relapsing polychondritis
- Discussion of the role of left atrial appendage closure in preventing stroke and systemic embolization
- Aducanumab (anti-amyloid therapy) is approved by the US FDA for the treatment of Alzheimer disease
- Extensive revision of the Thyroiditis section in Endocrine Disorders topic
- Substantial revision of the Nutritional Support section in the Nutritional Disorders & Obesity topic
- Substantial revision in the HIV Infection & AIDS chapter, including updates in the available therapeutic regimens
- Rewritten SARS-CoV-2 section and inclusion of SARS-CoV-2 information relevant to specific chapters throughout the textbook
- Extensive revision of Sexual & Gender Minority Health chapter, including sections on family planning and health care for transgender and gender diverse persons
Disclaimer
Official App Store Link
We do not host CURRENT Med Diag & Treatment on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Apple and passed their terms and conditions to be listed there. We recommend caution when installing it.
The App Store link for CURRENT Med Diag & Treatment is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
